Clinical Trial Update: Bronchoscopic Lung Volume Reduction Using Blood [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating bronchoscopic lung volume reduction using blood in emphysema patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Emphysema

Snippet

Sponsor: Chelsea and Westminster NHS Foundation Trust | Conditions: Emphysema | Phase 2 | Status: COMPLETED